On October 2, 2023, the Board of Directors of FibroGen, Inc. appointed Interim Chief Executive Officer Thane Wettig as Chief Executive Officer. Mr. Wettig held the position of Interim Chief Executive Officer since July 23, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | +1.96% | -9.57% | +17.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.34% | 103M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- FibroGen, Inc. Appoints Thane Wettig as Chief Executive Officer